CFRA Maintains Hold on Amgen, Raises Price Target to $223

CFRA analyst Kevin Huang maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $215 to $223.

Benzinga · 01/31/2020 17:50

CFRA analyst Kevin Huang maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $215 to $223.